Efficacy and Safety of Oxaliplatin, Bevacizumab and Oral S-1 for Advanced Recurrent Colorectal Cancer

Molecular and Clinical Oncology - United Kingdom
doi 10.3892/mco.2016.977
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

S-1 With Leucovorin and Oxaliplatin for Advanced Gastric Cancer

The Lancet Oncology
Oncology
2016English

Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian Carcinoma

Clinical Ovarian Cancer
2011English

FOLFIRI® and Bevacizumab in First-Line Treatment for Colorectal Cancer Patients: Safety, Efficacy and Genetic Polymorphisms

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2014English

Safety and Efficacy of Bevacizumab With Hypofractionated Stereotactic Irradiation for Recurrent Malignant Gliomas

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2009English

Evaluation of Safety of FOLFOX4 Regimen in Patients With Advanced and Recurrent Colorectal Cancer

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
2007English

Results of a Randomized and Controlled Clinical Trial Evaluating the Efficacy and Safety of Combination Therapy With Endostar and S-1 Combined With Oxaliplatin in Advanced Gastric Cancer

OncoTargets and Therapy
OncologyPharmacology
2013English

Longterm Control of Advanced and Recurrent Gastric Cancer (ARGC) by S-1

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2003English

PCN22 Safety Profile of Bevacizumab in Metastatic Colorectal Cancer

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

A Phase 1 Study of Irinotecan, Capecitabine (Xeloda®), and Oxaliplatin (IXO) in Patients With Advanced Colorectal Cancer

Clinical Colorectal Cancer
OncologyGastroenterology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy